•  
  •  
 

Aims & Scope

The AUIQ Complementary Biological System is an international, peer-reviewed, open-access journal that reports on all aspects Biological, Pharmaceutical, Medical and Health Sciences, the aim of this journal is to highlight research and development leading to provide high-quality and evidence-based articles and to create a global platform for hypothesis-driven and evidence-based articles in the area of Biological , Pharmaceutical, medical and health sciences.

AUIQ Complementary Biological System is an international peer reviewed journal publishing articles that emphasize the Biology, Molecular Biology , Genetics, Biotechnology, Environmental, Physiology, Biochemistry, Pharmaceutical, Health and Basic Medical Sciences. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed. The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms.

Articles that merely report observations are rarely accepted. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in Biology, Molecular Biology , Genetics, Biotechnology, Physiology, Biochemistry, Environmental, Pharmaceutical, Health and Basic Medical Sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.

Manuscripts should present novel preclinical findings addressing questions of biological significance to human disease. Studies that fail to do so may be rejected without review. Quantitative conclusions must be based on truly quantitative methods. AUIQ Complementary Biological Systems does not publish work on the actions of biological extracts of unknown chemical composition. Compounds studied must be of known chemical structure and concentration. The study must be reproducible; materials used must be available to other researchers so they can repeat the experiment. Clinical studies may be considered if they expand understanding of mechanism, but the journal does not encourage clinical trial reports.

Four common reasons for rejection include: out of scope (the manuscript does not conform to the goal of identification of mechanisms related to therapy for human disease); too preliminary (manuscript is based on a limited amount of experimental data diminishing significance); lack of novelty (manuscript is well done but does not address a significant question); unidentified structure (actions of biological extracts of unknown chemical composition).

Topics

Specific topics covered in the journal include:

Biology:

Molecular Biology, Genetics, Cytology, Physiology, Histology, and Environmental sciences.

Pharmaceutical Science:

Pharmacology and Toxicology, Pharmacognosy and phytomedicine , Clinical pharmacy and Pharmacy practice, Pharmaceutics and Industrial pharmacy, pharmaceutical chemistry and drug design, and Clinical chemistry.

Medical Science:

Microbiology, Molecular and Cellular Biology, Immunology, Pathology, Biochemistry, Public Health and Occupational.

Types of Articles:

The journal welcomes submissions of papers covering:

  • Original Study
  • Review
  • Rapid Communication
  • Case Report
  • Letter to the Editor
  • Special Issue